Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.75 - $1.33 $2,884 - $5,115
3,846 Added 4.59%
87,714 $68,000
Q1 2022

May 16, 2022

BUY
$1.09 - $1.83 $37,149 - $62,370
34,082 Added 68.46%
83,868 $109,000
Q4 2021

Feb 14, 2022

BUY
$1.63 - $2.83 $4,280 - $7,431
2,626 Added 5.57%
49,786 $82,000
Q3 2021

Nov 12, 2021

BUY
$2.45 - $3.45 $115,542 - $162,702
47,160 New
47,160 $125,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.